<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>VHT filings -- what changed, from SEC Form N-PORT | Mulden</title><description>Each N-PORT filing of VHT compared with the one before: positions added and dropped, the largest weight changes, turnover. Computed by Mulden from the filings; dated by filing period and SEC receipt.</description><link>https://themulden.com/</link><language>en</language><item><title>VHT: filing for 2026-05-31 -- 3 added, 12 dropped, turnover 6.9%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>408 positions became 399: 3 added (0.02% of the fund), 12 dropped (0.77%). Turnover proxy 6.9%. Largest increases: UnitedHealth Group Inc 3.95% to 5.46%; Eli Lilly &amp;amp; Co 12.57% to 14.06%; CVS Health Corp 1.51% to 1.83%; Elevance Health Inc 1.05% to 1.35%; Humana Inc 0.34% to 0.58%; REVOLUTION Medicines Inc 0.21% to 0.4%. Largest decreases: Abbott Laboratories 3.01% to 2.36%; Boston Scientific Corp 1.69% to 1.13%; McKesson Corp 1.82% to 1.45%; Medtronic PLC 1.86% to 1.5%; HCA Healthcare Inc 1.29% to 0.96%; Zoetis Inc 0.86% to 0.54%. New: agilon health Inc (0.02%), First Tracks Biotherapeutics Inc (0%), Hologic Inc (0%). Gone: Exact Sciences Corp (0.29%), Hologic Inc (0.25%), Amicus Therapeutics Inc (0.06%), Arcellx Inc (0.05%), Terns Pharmaceuticals Inc (0.04%), Soleno Therapeutics Inc (0.03%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 29 Jul 2026 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2026-02-28 -- 5 added, 12 dropped, turnover 9.6%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>415 positions became 408: 5 added (0.2% of the fund), 12 dropped (0.41%). Turnover proxy 9.6%. Largest increases: Johnson &amp;amp; Johnson 4.62% to 8.77%; AbbVie Inc 5.06% to 6.09%; Merck &amp;amp; Co Inc 3.91% to 4.59%; Gilead Sciences Inc 2.33% to 2.75%; Bristol-Myers Squibb Co 1.5% to 1.89%; Amgen Inc 2.78% to 3.1%. Largest decreases: Vanguard Cmt Funds-Vanguard Market Liquidity Fund 3.85% to 0.07%; Boston Scientific Corp 2.25% to 1.69%; Thermo Fisher Scientific Inc 3.33% to 2.92%; Intuitive Surgical Inc 3.07% to 2.68%; Eli Lilly &amp;amp; Co 12.93% to 12.57%; Abbott Laboratories 3.35% to 3.01%. New: Medline Inc (0.12%), Indivior Pharmaceuticals Inc (0.04%), Definium Therapeutics Inc (0.02%), Tilray Brands Inc (0.01%), Atrium Therapeutics Inc (0%). Gone: Avidity Biosciences Inc (0.12%), Merus NV (0.08%), Indivior PLC (0.04%), Akero Therapeutics Inc (0.04%), Cidara Therapeutics Inc (0.04%), Avadel Pharmaceuticals PLC (0.03%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2025-11-30 -- 32 added, 16 dropped, turnover 7.3%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>399 positions became 415: 32 added (0.37% of the fund), 16 dropped (0.46%). Turnover proxy 7.3%. Largest increases: Eli Lilly &amp;amp; Co 10.17% to 12.93%; Vanguard Cmt Funds-Vanguard Market Liquidity Fund 3.21% to 3.85%; Merck &amp;amp; Co Inc 3.64% to 3.91%; Insmed Inc 0.45% to 0.66%; McKesson Corp 1.48% to 1.64%; Regeneron Pharmaceuticals Inc 1.06% to 1.21%. Largest decreases: Abbott Laboratories 3.98% to 3.35%; Johnson &amp;amp; Johnson 5.07% to 4.62%; Boston Scientific Corp 2.69% to 2.25%; Stryker Corp 2.32% to 1.91%; UnitedHealth Group Inc 4.55% to 4.19%; Zoetis Inc 1.2% to 0.85%. New: Indivior PLC (0.04%), Cidara Therapeutics Inc (0.04%), Celcuity Inc (0.02%), UroGen Pharma Ltd (0.02%), Trevi Therapeutics Inc (0.02%), Nektar Therapeutics (0.02%). Gone: Royalty Pharma PLC (0.24%), CRISPR Therapeutics AG (0.07%), Xenon Pharmaceuticals Inc (0.04%), Premier Inc (0.04%), 89bio Inc (0.02%), ATAI Life Sciences NV (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 28 Jan 2026 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2025-08-31 -- 15 added, 17 dropped, turnover 5.3%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>401 positions became 399: 15 added (0.25% of the fund), 17 dropped (0.25%). Turnover proxy 5.3%. Largest increases: Thermo Fisher Scientific Inc 2.77% to 3.21%; Vanguard Cmt Funds-Vanguard Market Liquidity Fund 2.78% to 3.21%; AbbVie Inc 5.01% to 5.39%; Johnson &amp;amp; Johnson 4.72% to 5.07%; Alnylam Pharmaceuticals Inc 0.71% to 1%; N/A 0% to 0.26%. Largest decreases: Intuitive Surgical Inc 3.54% to 2.92%; Eli Lilly &amp;amp; Co 10.71% to 10.17%; UnitedHealth Group Inc 5% to 4.55%; Elevance Health Inc 1.6% to 1.24%; Vertex Pharmaceuticals Inc 2.05% to 1.73%; Centene Corp 0.51% to 0.25%. New: Tempus AI Inc (0.12%), Xeris Biopharma Holdings Inc (0.02%), Newamsterdam Pharma Co NV (0.02%), Akebia Therapeutics Inc (0.01%), Axogen Inc (0.01%), ChromaDex Corp (0.01%). Gone: Blueprint Medicines Corp (0.12%), Amedisys Inc (0.06%), SpringWorks Therapeutics Inc (0.05%), Sage Therapeutics Inc (0.01%), Verve Therapeutics Inc (0.01%), iTeos Therapeutics Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 28 Oct 2025 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2025-05-31 -- 3 added, 14 dropped, turnover 6.3%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>412 positions became 401: 3 added (0% of the fund), 14 dropped (0.26%). Turnover proxy 6.3%. Largest increases: Vanguard Cmt Funds-Vanguard Market Liquidity Fund 2.17% to 2.78%; HCA Healthcare Inc 0.95% to 1.3%; Boston Scientific Corp 2.46% to 2.79%; Abbott Laboratories 3.85% to 4.17%; McKesson Corp 1.33% to 1.64%; Intuitive Surgical Inc 3.27% to 3.54%. Largest decreases: UnitedHealth Group Inc 7.04% to 5%; Eli Lilly &amp;amp; Co 11.94% to 10.71%; Thermo Fisher Scientific Inc 3.24% to 2.77%; AbbVie Inc 5.34% to 5.01%; Regeneron Pharmaceuticals Inc 1.22% to 0.95%; N/A 0.2% to 0%. New: Alumis Inc (0%), Outset Medical Inc (0%), Seres Therapeutics Inc (0%). Gone: Intra-Cellular Therapies Inc (0.2%), Patterson Cos Inc (0.04%), Accolade Inc (0.01%), Paragon 28 Inc (0.01%), Nevro Corp (0%), ACELYRIN Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 29 Jul 2025 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2025-02-28 -- 0 added, 5 dropped, turnover 5.8%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>417 positions became 412: 0 added (0% of the fund), 5 dropped (0.24%). Turnover proxy 5.8%. Largest increases: Eli Lilly &amp;amp; Co 10.3% to 11.94%; AbbVie Inc 4.69% to 5.34%; Abbott Laboratories 3.31% to 3.85%; Gilead Sciences Inc 1.85% to 2.29%; Boston Scientific Corp 2.14% to 2.46%; Johnson &amp;amp; Johnson 4.51% to 4.75%. Largest decreases: UnitedHealth Group Inc 9.03% to 7.04%; Merck &amp;amp; Co Inc 3.94% to 3.58%; Danaher Corp 2.5% to 2.17%; Illumina Inc 0.37% to 0.23%; Cigna Group/The 1.51% to 1.39%; West Pharmaceutical Services Inc 0.38% to 0.27%. Gone: Catalent Inc (0.18%), Inari Medical Inc (0.04%), Avid Bioservices Inc (0.01%), Revance Therapeutics Inc (0.01%), RAPT Therapeutics Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 25 Apr 2025 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2024-11-30 -- 24 added, 24 dropped, turnover 6.2%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>417 positions became 417: 24 added (0.25% of the fund), 24 dropped (0.17%). Turnover proxy 6.2%. Largest increases: UnitedHealth Group Inc 8.24% to 9.03%; Intuitive Surgical Inc 2.64% to 3.09%; Bristol-Myers Squibb Co 1.53% to 1.92%; Gilead Sciences Inc 1.49% to 1.85%; Abbott Laboratories 2.98% to 3.31%; Boston Scientific Corp 1.82% to 2.14%. Largest decreases: Eli Lilly &amp;amp; Co 11.75% to 10.3%; Regeneron Pharmaceuticals Inc 1.94% to 1.3%; Vanguard Cmt Funds-Vanguard Market Liquidity Fund 2.58% to 2.1%; Elevance Health Inc 1.96% to 1.51%; Danaher Corp 2.87% to 2.5%; Thermo Fisher Scientific Inc 3.56% to 3.24%. New: Summit Therapeutics Inc (0.04%), Concentra Group Holdings Parent Inc (0.03%), Waystar Holding Corp (0.02%), BrightSpring Health Services Inc (0.02%), LifeStance Health Group Inc (0.02%), Avadel Pharmaceuticals PLC (0.02%). Gone: Axonics Inc (0.05%), R1 RCM Inc (0.04%), Longboard Pharmaceuticals Inc (0.02%), Silk Road Medical Inc (0.02%), PetIQ Inc (0.01%), Sharecare Inc (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 27 Jan 2025 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2024-08-31 -- 28 added, 17 dropped, turnover 6.4%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>406 positions became 417: 28 added (0.28% of the fund), 17 dropped (0.19%). Turnover proxy 6.4%. Largest increases: Vanguard Cmt Funds-Vanguard Market Liquidity Fund 0% to 2.58%; Eli Lilly &amp;amp; Co 11.04% to 11.75%; UnitedHealth Group Inc 7.64% to 8.24%; Intuitive Surgical Inc 2.36% to 2.64%; Alnylam Pharmaceuticals Inc 0.31% to 0.5%; Regeneron Pharmaceuticals Inc 1.75% to 1.94%. Largest decreases: Merck &amp;amp; Co Inc 5.3% to 3.8%; Johnson &amp;amp; Johnson 5.81% to 4.59%; Moderna Inc 0.77% to 0.38%; Dexcom Inc 0.77% to 0.4%; Edwards Lifesciences Corp 0.88% to 0.64%; Pfizer Inc 2.7% to 2.48%. New: Dyne Therapeutics Inc (0.04%), Vera Therapeutics Inc (0.02%), Arcutis Biotherapeutics Inc (0.02%), Apogee Therapeutics Inc (0.02%), Kiniksa Pharmaceuticals International Plc (0.02%), Longboard Pharmaceuticals Inc (0.02%). Gone: Cerevel Therapeutics Holdings Inc (0.05%), Shockwave Medical Inc (0.04%), Summit Therapeutics Inc (0.02%), Deciphera Pharmaceuticals Inc (0.02%), Morphic Holding Inc (0.02%), Atrion Corp (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 28 Oct 2024 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2024-05-31 -- 4 added, 9 dropped, turnover 5.1%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>411 positions became 406: 4 added (0.43% of the fund), 9 dropped (0.56%). Turnover proxy 5.1%. Largest increases: Eli Lilly &amp;amp; Co 9.96% to 11.04%; Amgen Inc 2.4% to 2.73%; Moderna Inc 0.49% to 0.77%; Boston Scientific Corp 1.59% to 1.85%; Pfizer Inc 2.46% to 2.7%; Vertex Pharmaceuticals Inc 1.78% to 1.96%. Largest decreases: Johnson &amp;amp; Johnson 6.36% to 5.81%; Abbott Laboratories 3.37% to 2.96%; Bristol-Myers Squibb Co 1.74% to 1.39%; AbbVie Inc 5.09% to 4.75%; CVS Health Corp 1.56% to 1.28%; Zoetis Inc 1.5% to 1.3%. New: Labcorp Holdings Inc (0.28%), Solventum Corp (0.15%), Agenus Inc (0%), Vanguard Cmt Funds-Vanguard Market Liquidity Fund (0%). Gone: Laboratory Corp of America Holdings (0.31%), Karuna Therapeutics Inc (0.16%), Cymabay Therapeutics Inc (0.04%), Alpine Immune Sciences Inc (0.02%), Inhibrx Inc (0.01%), Agiliti Inc (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 26 Jul 2024 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2024-02-29 -- 21 added, 15 dropped, turnover 6.6%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>405 positions became 411: 21 added (0.62% of the fund), 15 dropped (1.05%). Turnover proxy 6.6%. Largest increases: Eli Lilly &amp;amp; Co 8.65% to 9.96%; Merck &amp;amp; Co Inc 4.72% to 5.28%; AbbVie Inc 4.56% to 5.09%; Intuitive Surgical Inc 1.98% to 2.22%; Cigna Group/The 1.41% to 1.63%; Thermo Fisher Scientific Inc 3.47% to 3.6%. Largest decreases: UnitedHealth Group Inc 9.34% to 7.49%; Pfizer Inc 3.12% to 2.46%; Johnson &amp;amp; Johnson 6.76% to 6.36%; Humana Inc 1.1% to 0.71%; Gilead Sciences Inc 1.73% to 1.47%; Amgen Inc 2.61% to 2.4%. New: Cooper Cos Inc/The (0.3%), Roivant Sciences Ltd (0.05%), Cymabay Therapeutics Inc (0.04%), Ardelyx Inc (0.03%), Ideaya Biosciences Inc (0.03%), UFP Technologies Inc (0.02%). Gone: Seagen Inc (0.54%), Cooper Cos Inc/The (0.3%), ImmunoGen Inc (0.12%), Mirati Therapeutics Inc (0.05%), Point Biopharma Global Inc (0.02%), SomaLogic Inc (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 29 Apr 2024 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2023-11-30 -- 3 added, 11 dropped, turnover 5.2%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>413 positions became 405: 3 added (0% of the fund), 11 dropped (0.67%). Turnover proxy 5.2%. Largest increases: UnitedHealth Group Inc 7.8% to 9.34%; Eli Lilly &amp;amp; Co 7.86% to 8.65%; Elevance Health Inc 1.84% to 2.06%; Amgen Inc 2.4% to 2.61%; McKesson Corp 0.99% to 1.16%; Abbott Laboratories 3.14% to 3.29%. Largest decreases: Bristol-Myers Squibb Co 2.28% to 1.88%; Pfizer Inc 3.51% to 3.12%; Danaher Corp 3.22% to 2.84%; Thermo Fisher Scientific Inc 3.77% to 3.47%; Moderna Inc 0.65% to 0.46%; Align Technology Inc 0.47% to 0.28%. New: Scilex Holding Co (0%), Mural Oncology PLC (0%), Cano Health Inc (0%). Gone: Horizon Therapeutics Plc (0.43%), Syneos Health Inc (0.08%), Reata Pharmaceuticals Inc (0.07%), NuVasive Inc (0.04%), NextGen Healthcare Inc (0.02%), Vanguard Cmt Funds-Vanguard Market Liquidity Fund (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 29 Jan 2024 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2023-08-31 -- 19 added, 9 dropped, turnover 4.8%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>403 positions became 413: 19 added (0.19% of the fund), 9 dropped (0.24%). Turnover proxy 4.8%. Largest increases: Eli Lilly &amp;amp; Co 6.27% to 7.86%; Danaher Corp 2.87% to 3.22%; Amgen Inc 2.13% to 2.4%; Zoetis Inc 1.37% to 1.55%; Thermo Fisher Scientific Inc 3.61% to 3.77%; Becton Dickinson &amp;amp; Co 1.19% to 1.34%. Largest decreases: Johnson &amp;amp; Johnson 7.33% to 6.83%; UnitedHealth Group Inc 8.23% to 7.8%; Pfizer Inc 3.86% to 3.51%; Merck &amp;amp; Co Inc 5.06% to 4.85%; Bristol-Myers Squibb Co 2.48% to 2.28%; CVS Health Corp 1.62% to 1.46%. New: Fortrea Holdings Inc (0.04%), Viking Therapeutics Inc (0.02%), Biohaven Ltd (0.02%), 89bio Inc (0.02%), Day One Biopharmaceuticals Inc (0.01%), Amylyx Pharmaceuticals Inc (0.01%). Gone: Prometheus Biosciences Inc (0.08%), IVERIC bio Inc (0.08%), Heska Corp (0.02%), Chinook Therapeutics Inc (0.02%), DICE Therapeutics Inc (0.02%), Figs Inc (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 30 Oct 2023 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2023-05-31 -- 1 added, 6 dropped, turnover 4.5%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>408 positions became 403: 1 added (0% of the fund), 6 dropped (0.26%). Turnover proxy 4.5%. Largest increases: Eli Lilly &amp;amp; Co 4.54% to 6.27%; Intuitive Surgical Inc 1.48% to 1.97%; Merck &amp;amp; Co Inc 4.86% to 5.06%; UnitedHealth Group Inc 8.05% to 8.23%; Vertex Pharmaceuticals Inc 1.35% to 1.5%; Boston Scientific Corp 1.21% to 1.33%. Largest decreases: AbbVie Inc 4.92% to 4.41%; CVS Health Corp 1.98% to 1.62%; Pfizer Inc 4.12% to 3.86%; Cigna Group/The 1.61% to 1.37%; Thermo Fisher Scientific Inc 3.84% to 3.61%; Danaher Corp 3.09% to 2.87%. New: Geron Corp (0%). Gone: Vanguard Cmt Funds-Vanguard Market Liquidity Fund (0.11%), Oak Street Health Inc (0.07%), Signify Health Inc (0.04%), Myovant Sciences Ltd (0.02%), Cardiovascular Systems Inc (0.01%), Geron Corp (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 31 Jul 2023 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2023-02-28 -- 21 added, 11 dropped, turnover 5.1%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>398 positions became 408: 21 added (0.84% of the fund), 11 dropped (0.47%). Turnover proxy 5.1%. Largest increases: Stryker Corp 1.33% to 1.62%; Medtronic PLC 1.76% to 1.99%; Merck &amp;amp; Co Inc 4.66% to 4.86%; Zoetis Inc 1.21% to 1.41%; Thermo Fisher Scientific Inc 3.67% to 3.84%; Align Technology Inc 0.25% to 0.42%. Largest decreases: Pfizer Inc 4.7% to 4.12%; Johnson &amp;amp; Johnson 7.83% to 7.28%; UnitedHealth Group Inc 8.59% to 8.05%; Eli Lilly &amp;amp; Co 5.01% to 4.54%; Amgen Inc 2.56% to 2.24%; CVS Health Corp 2.23% to 1.98%. New: GE HealthCare Technologies Inc (0.5%), Vanguard Cmt Funds-Vanguard Market Liquidity Fund (0.11%), Embecta Corp (0.03%), Catalyst Pharmaceuticals Inc (0.03%), Pliant Therapeutics Inc (0.02%), Akero Therapeutics Inc (0.02%). Gone: ABIOMED Inc (0.29%), LHC Group Inc (0.08%), 1Life Healthcare Inc (0.04%), Meridian Bioscience Inc (0.02%), N/A (0.01%), Sorrento Therapeutics Inc (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 28 Apr 2023 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2022-11-30 -- 1 added, 6 dropped, turnover 5%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>403 positions became 398: 1 added (0% of the fund), 6 dropped (0.46%). Turnover proxy 5%. Largest increases: Merck &amp;amp; Co Inc 3.94% to 4.66%; Eli Lilly &amp;amp; Co 4.45% to 5.01%; AbbVie Inc 4.34% to 4.76%; Gilead Sciences Inc 1.38% to 1.76%; Intuitive Surgical Inc 1.34% to 1.62%; Regeneron Pharmaceuticals Inc 1.13% to 1.36%. Largest decreases: Medtronic PLC 2.16% to 1.76%; UnitedHealth Group Inc 8.92% to 8.59%; Thermo Fisher Scientific Inc 3.9% to 3.67%; Edwards Lifesciences Corp 1.03% to 0.8%; Danaher Corp 3.35% to 3.16%; Abbott Laboratories 3.31% to 3.15%. New: OmniAb Inc (0%). Gone: Biohaven Pharmaceutical Holding Co Ltd (0.16%), Change Healthcare Inc (0.11%), Global Blood Therapeutics Inc (0.08%), ChemoCentryx Inc (0.05%), Covetrus Inc (0.04%), Hanger Inc (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 27 Jan 2023 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2022-08-31 -- 27 added, 62 dropped, turnover 5%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>438 positions became 403: 27 added (0.32% of the fund), 62 dropped (0.76%). Turnover proxy 5%. Largest increases: UnitedHealth Group Inc 8.18% to 8.92%; Danaher Corp 2.97% to 3.35%; Alnylam Pharmaceuticals Inc 0.26% to 0.43%; McKesson Corp 0.88% to 1%; Centene Corp 0.83% to 0.96%; CVS Health Corp 2.23% to 2.35%. Largest decreases: Pfizer Inc 5.2% to 4.64%; Johnson &amp;amp; Johnson 8.26% to 7.75%; Abbott Laboratories 3.63% to 3.31%; Bristol-Myers Squibb Co 2.93% to 2.68%; AbbVie Inc 4.55% to 4.34%; Medtronic PLC 2.35% to 2.16%. New: agilon health Inc (0.08%), R1 RCM Inc (0.06%), Alignment Healthcare Inc (0.02%), Enhabit Inc (0.01%), DocGo Inc (0.01%), Cytek Biosciences Inc (0.01%). Gone: Cerner Corp (0.49%), R1 RCM Inc (0.05%), Turning Point Therapeutics Inc (0.03%), Embecta Corp (0.02%), Tivity Health Inc (0.02%), Natus Medical Inc (0.02%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 31 Oct 2022 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2022-05-31 -- 9 added, 9 dropped, turnover 6%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>438 positions became 438: 9 added (0.28% of the fund), 9 dropped (0.29%). Turnover proxy 6%. Largest increases: Eli Lilly &amp;amp; Co 3.53% to 4.45%; Johnson &amp;amp; Johnson 7.52% to 8.26%; Merck &amp;amp; Co Inc 3.36% to 4.06%; Pfizer Inc 4.57% to 5.2%; UnitedHealth Group Inc 7.79% to 8.18%; Amgen Inc 2.23% to 2.53%. Largest decreases: Intuitive Surgical Inc 1.8% to 1.42%; Align Technology Inc 0.67% to 0.36%; Illumina Inc 0.83% to 0.62%; IDEXX Laboratories Inc 0.79% to 0.58%; HCA Healthcare Inc 1.11% to 0.92%; Dexcom Inc 0.7% to 0.5%. New: Azenta Inc (0.1%), QuidelOrtho Corp (0.08%), Enovis Corp (0.05%), Embecta Corp (0.02%), Zimvie Inc (0.01%), N/A (0.01%). Gone: Arena Pharmaceuticals Inc (0.1%), Quidel Corp (0.07%), Ortho Clinical Diagnostics Holdings PLC (0.04%), Ginkgo Bioworks Holdings Inc (0.03%), Zogenix Inc (0.02%), Intersect ENT Inc (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 01 Aug 2022 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2022-02-28 -- 40 added, 53 dropped, turnover 7.3%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>451 positions became 438: 40 added (0.36% of the fund), 53 dropped (0.58%). Turnover proxy 7.3%. Largest increases: AbbVie Inc 3.46% to 4.53%; UnitedHealth Group Inc 7.13% to 7.79%; Bristol-Myers Squibb Co 2.04% to 2.65%; Johnson &amp;amp; Johnson 6.98% to 7.52%; CVS Health Corp 1.99% to 2.37%; Amgen Inc 1.94% to 2.23%. Largest decreases: Moderna Inc 2.05% to 0.91%; Pfizer Inc 5.11% to 4.57%; Thermo Fisher Scientific Inc 4.23% to 3.71%; Danaher Corp 3.51% to 3.06%; Dexcom Inc 0.93% to 0.7%; Zoetis Inc 1.79% to 1.59%. New: Ortho Clinical Diagnostics Holdings PLC (0.04%), Cassava Sciences Inc (0.03%), Ginkgo Bioworks Holdings Inc (0.03%), Aurinia Pharmaceuticals Inc (0.02%), IVERIC bio Inc (0.02%), Celldex Therapeutics Inc (0.02%). Gone: Hill-Rom Holdings Inc (0.18%), PPD Inc (0.1%), Dicerna Pharmaceuticals Inc (0.04%), Magellan Health Inc (0.04%), Vocera Communications Inc (0.03%), Triple-S Management Corp (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 29 Apr 2022 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2021-11-30 -- 1 added, 48 dropped, turnover 5%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>498 positions became 451: 1 added (0.01% of the fund), 48 dropped (0.21%). Turnover proxy 5%. Largest increases: Pfizer Inc 4.14% to 5.11%; UnitedHealth Group Inc 6.36% to 7.13%; Thermo Fisher Scientific Inc 3.52% to 4.23%; Zoetis Inc 1.57% to 1.79%; Anthem Inc 1.48% to 1.69%; Abbott Laboratories 3.61% to 3.8%. Largest decreases: Medtronic PLC 2.9% to 2.45%; Bristol-Myers Squibb Co 2.41% to 2.04%; Johnson &amp;amp; Johnson 7.33% to 6.98%; Biogen Inc 0.83% to 0.6%; Illumina Inc 1.07% to 0.91%; Amgen Inc 2.1% to 1.94%. New: 2seventy bio Inc (0.01%). Gone: Acceleron Pharma Inc (0.12%), Inovalon Holdings Inc (0.05%), Translate Bio Inc (0.03%), Kadmon Holdings Inc (0.01%), ICON PLC (0%), Catalyst Pharmaceuticals Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 31 Jan 2022 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2021-08-31 -- 5 added, 7 dropped, turnover 6.3%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>500 positions became 498: 5 added (0.17% of the fund), 7 dropped (1.03%). Turnover proxy 6.3%. Largest increases: Moderna Inc 1.02% to 1.92%; Eli Lilly &amp;amp; Co 2.84% to 3.39%; Danaher Corp 2.87% to 3.35%; Pfizer Inc 3.78% to 4.14%; Thermo Fisher Scientific Inc 3.23% to 3.52%; Intuitive Surgical Inc 1.73% to 2%. Largest decreases: UnitedHealth Group Inc 6.83% to 6.36%; Johnson &amp;amp; Johnson 7.78% to 7.33%; Cigna Corp 1.59% to 1.2%; Amgen Inc 2.4% to 2.1%; Merck &amp;amp; Co Inc 3.36% to 3.11%; Anthem Inc 1.7% to 1.48%. New: Organon &amp;amp; Co (0.14%), Doximity Inc (0.03%), Alder Biopharmaceuticals Inc (0%), ICON PLC (0%), Geron Corp (0%). Gone: Alexion Pharmaceuticals Inc (0.68%), PRA Health Sciences Inc (0.19%), Vanguard Cmt Funds-Vanguard Market Liquidity Fund (0.07%), Cantel Medical Corp (0.04%), Luminex Corp (0.03%), Constellation Pharmaceuticals Inc (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 29 Oct 2021 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2021-05-31 -- 63 added, 9 dropped, turnover 5.3%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>446 positions became 500: 63 added (0.92% of the fund), 9 dropped (0.43%). Turnover proxy 5.3%. Largest increases: UnitedHealth Group Inc 5.96% to 6.83%; CVS Health Corp 1.68% to 1.98%; Anthem Inc 1.44% to 1.7%; Pfizer Inc 3.51% to 3.78%; Danaher Corp 2.65% to 2.87%; Moderna Inc 0.81% to 1.02%. Largest decreases: Eli Lilly &amp;amp; Co 3.33% to 2.84%; Abbott Laboratories 4% to 3.61%; Illumina Inc 1.21% to 1.03%; Thermo Fisher Scientific Inc 3.36% to 3.23%; Teladoc Health Inc 0.48% to 0.36%; Merck &amp;amp; Co Inc 3.47% to 3.36%. New: Oak Street Health Inc (0.1%), Vanguard Cmt Funds-Vanguard Market Liquidity Fund (0.07%), Maravai LifeSciences Holdings Inc (0.06%), Vir Biotechnology Inc (0.05%), Outset Medical Inc (0.03%), GoodRx Holdings Inc (0.03%). Gone: Varian Medical Systems Inc (0.3%), HMS Holdings Corp (0.06%), GenMark Diagnostics Inc (0.02%), NantKwest Inc (0.02%), Five Prime Therapeutics Inc (0.01%), Oxford Immunotec Global PLC (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 30 Jul 2021 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2021-02-28 -- 39 added, 13 dropped, turnover 5.4%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>420 positions became 446: 39 added (0.64% of the fund), 13 dropped (0.22%). Turnover proxy 5.4%. Largest increases: Eli Lilly and Co 2.5% to 3.33%; Johnson &amp;amp; Johnson 7.6% to 7.87%; Illumina Inc 0.94% to 1.21%; Abbott Laboratories 3.82% to 4%; DexCom Inc 0.59% to 0.72%; Horizon Therapeutics Plc 0.25% to 0.38%. Largest decreases: Pfizer Inc 4.24% to 3.51%; Merck &amp;amp; Co Inc 4.04% to 3.47%; UnitedHealth Group Inc 6.36% to 5.96%; Thermo Fisher Scientific Inc 3.66% to 3.36%; Danaher Corp 2.85% to 2.65%; Bristol-Myers Squibb Co 2.81% to 2.61%. New: Schrodinger Inc/United States (0.07%), Bridgebio Pharma Inc (0.07%), Owens &amp;amp; Minor Inc (0.05%), ModivCare Inc (0.03%), Beam Therapeutics Inc (0.03%), American Well Corp (0.03%). Gone: Vanguard Cmt Funds-Vanguard Market Liquidity Fund (0.1%), BioTelemetry Inc (0.04%), Providence Service Corp/The (0.03%), Eidos Therapeutics Inc (0.02%), N/A (0.01%), BioSpecifics Technologies Corp (0.01%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 29 Apr 2021 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2020-11-30 -- 5 added, 14 dropped, turnover 6.3%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>429 positions became 420: 5 added (0.87% of the fund), 14 dropped (1.27%). Turnover proxy 6.3%. Largest increases: Moderna Inc 0.36% to 0.83%; Align Technology Inc 0.46% to 0.72%; UnitedHealth Group Inc 6.11% to 6.36%; Stryker Corp 1.38% to 1.57%; AbbVie Inc 3.36% to 3.55%; Danaher Corp 2.67% to 2.85%. Largest decreases: Johnson &amp;amp; Johnson 8.34% to 7.6%; Amgen Inc 3.08% to 2.6%; Merck &amp;amp; Co Inc 4.46% to 4.04%; Vertex Pharmaceuticals Inc 1.49% to 1.18%; Regeneron Pharmaceuticals Inc 1.29% to 1.04%; Biogen Inc 1.03% to 0.78%. New: Viatris Inc (0.41%), Seagen Inc (0.41%), Travere Therapeutics Inc (0.02%), N/A (0.01%), 1Life Healthcare Inc (0.01%). Gone: Seattle Genetics Inc (0.39%), Mylan NV (0.17%), Immunomedics Inc (0.17%), Momenta Pharmaceuticals Inc (0.12%), MyoKardia Inc (0.11%), Livongo Health Inc (0.11%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 29 Jan 2021 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2020-08-31 -- 49 added, 5 dropped, turnover 5.4%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>385 positions became 429: 49 added (1.13% of the fund), 5 dropped (0.05%). Turnover proxy 5.4%. Largest increases: Thermo Fisher Scientific Inc 3.1% to 3.53%; Danaher Corp 2.31% to 2.67%; Abbott Laboratories 3.71% to 3.98%; Intuitive Surgical Inc 1.48% to 1.75%; Veeva Systems Inc 0.64% to 0.77%; HCA Healthcare Inc 0.64% to 0.76%. Largest decreases: Gilead Sciences Inc 2.18% to 1.64%; Pfizer Inc 4.68% to 4.31%; Johnson &amp;amp; Johnson 8.66% to 8.34%; Eli Lilly and Co 2.92% to 2.63%; UnitedHealth Group Inc 6.39% to 6.11%; Cigna Corp 1.63% to 1.36%. New: Moderna Inc (0.36%), Novavax Inc (0.12%), Livongo Health Inc (0.11%), Royalty Pharma PLC (0.07%), Adaptive Biotechnologies Corp (0.06%), NanoString Technologies Inc (0.03%). Gone: Portola Pharmaceuticals Inc (0.03%), Stemline Therapeutics Inc (0.01%), Progenics Pharmaceuticals Inc (0.01%), N/A (0%), Evofem Biosciences Inc (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 29 Oct 2020 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2020-05-31 -- 3 added, 5 dropped, turnover 5.5%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>387 positions became 385: 3 added (0.14% of the fund), 5 dropped (1.62%). Turnover proxy 5.5%. Largest increases: UnitedHealth Group Inc 5.94% to 6.39%; Regeneron Pharmaceuticals Inc 0.89% to 1.27%; AbbVie Inc 3.12% to 3.49%; Abbott Laboratories 3.34% to 3.71%; Thermo Fisher Scientific Inc 2.86% to 3.1%; Eli Lilly and Co 2.69% to 2.92%. Largest decreases: Medtronic PLC 3.32% to 2.92%; Bristol-Myers Squibb Co 3.4% to 3.1%; Merck &amp;amp; Co Inc 4.82% to 4.55%; HCA Healthcare Inc 0.85% to 0.64%; Biogen Inc 1.4% to 1.23%; Stryker Corp 1.58% to 1.46%. New: Vanguard Cmt Funds-Vanguard Market Liquidity Fund (0.14%), N/A (0%), Evofem Biosciences Inc (0%). Gone: Allergan plc (1.54%), Forty Seven Inc. (0.04%), Ra Pharmaceuticals Inc. (0.03%), Akorn Inc. (0%), Corium International Inc. (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 30 Jul 2020 12:00:00 GMT</pubDate></item><item><title>VHT: filing for 2020-02-29 -- 6 added, 21 dropped, turnover 5.4%</title><link>https://themulden.com/funds/vht/</link><guid isPermaLink="true">https://themulden.com/funds/vht/</guid><description>402 positions became 387: 6 added (0.14% of the fund), 21 dropped (1.92%). Turnover proxy 5.4%. Largest increases: Bristol-Myers Squibb Co. 2.46% to 3.4%; Johnson &amp;amp; Johnson 8.32% to 8.73%; Eli Lilly &amp;amp; Co. 2.34% to 2.69%; Zoetis Inc. 1.32% to 1.56%; Gilead Sciences Inc. 1.95% to 2.16%; Regeneron Pharmaceuticals Inc. 0.68% to 0.89%. Largest decreases: CVS Health Corp. 2.24% to 1.89%; Pfizer Inc. 4.8% to 4.48%; Merck &amp;amp; Co. Inc. 5.12% to 4.82%; Amgen Inc. 3.23% to 2.94%; UnitedHealth Group Inc. 6.08% to 5.94%; Sage Therapeutics Inc. 0.18% to 0.06%. New: Envista Holdings Corp. (0.07%), PPD Inc. (0.05%), Option Care Health Inc. (0.01%), Alder Biopharmaceuticals Inc. (0%), Corium International Inc. (0%), Precigen Inc. (0%). Gone: Celgene Corp. (1.13%), WellCare Health Plans Inc. (0.37%), Medicines Co. (0.15%), Spark Therapeutics Inc. (0.09%), Cambrex Corp. (0.05%), Audentes Therapeutics Inc. (0.03%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 29 Apr 2020 12:00:00 GMT</pubDate></item></channel></rss>